You are here

  • Home
  • Archive
  • Volume 28, Issue Suppl 1
  • 4CPS-318 Compounding tacrolimus ophthalmic ointment 0.02% in the treatment of inflammatory and autoimmune ophthalmic syndromes: effectiveness and safety assessment

Alerts

Article menu

Download PDFPDF

Section 4: Clinical pharmacy services
4CPS-318 Compounding tacrolimus ophthalmic ointment 0.02% in the treatment of inflammatory and autoimmune ophthalmic syndromes: effectiveness and safety assessment
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address